Clinical Trials
It used to be that by five or six hours after a stroke, we had to say ‘I’m so sorry, you arrived too late to be treated’. But this is a new world - Gregory Albers MD
image by: ventanamedia
HWN Recommends
Stanford-led clinical trial shows broader benefits of acute-stroke therapy
A 38-center clinical trial sponsored by the National Institutes of Health and led by researchers at the Stanford University School of Medicine has shown that far more people than previously thought can benefit from an emergency procedure for acute ischemic stroke.
The improved outcomes were achieved through the use of brain-imaging software developed at Stanford. The software helps identify stroke patients who could benefit from a clot-removal procedure, known as thrombectomy, after the window of time during which it has generally been considered helpful has closed. Some patients showed dramatic improvement even when their brain clots were removed as long as 10 hours after…
Resources
Clinical trial uses stem cells to help patients recover from stroke
"It's the most innovative trial available for stroke patients today, and one of the best studies I've ever seen," he said. "If we continue to see positive results and the FDA approves this treatment, it can have a tremendous positive effect on the lives of patients recovering from stroke."
$45 million clinical trial to test sleep apnea treatment in stroke survivors nationwide
After a stroke, most patients have sleep apnea. A University of Michigan-led clinical trial will investigate whether treating it right away will improve outcomes.
Stroke drug demonstrates safety in clinical trial
A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps Research Institute (TSRI). The trial results, announced by pharmaceutical company ZZ Biotech, also show that 3K3A-APC substantially reduced hemorrhage volume and hemorrhage incidence in patients.
PISCES III
PISCES III is a clinical research study to determine whether stem cells injected into a damaged area of the brain can improve function in people with ongoing disability after an ischemic stroke (a stroke that occurs when blood flow to the brain is blocked, such as by a clot). This study is open to U.S. participants.
Vivistim
If you suffered a stroke at least 9 months ago, but not more than 10 years ago, and struggle with hand and arm movement, the Vivistim Clinical Study may be right for you.
Stanford-led clinical trial shows broader benefits of acute-stroke therapy
In a multicenter study led by Stanford researchers, the number of stroke patients who died or required confinement to nursing homes was nearly cut in half, the biggest improvement seen in any stroke-related trial to date.
CenterWatch
A listing of Stroke medical research trials actively recruiting patient volunteers.
ClinicalConnection
ClinicalConnection serves as more than a Study Participant recruiter, the company serves as the connection between Study Participants and the Clinical Investigators nationwide that are conducting clinical trials.
ClinicalTrials.gov
Search engine for information on clinical trials due to stroke.
Stroke Trials Registry
Welcome to the Stroke Trials Registry, a continuously updated registry of randomized clinical trials in stroke and cerebrovascular disease. This project is a free public service from the Internet Stroke Center at Washington University School of Medicine; with support from the American Stroke Association and the National Institute of Neurological Disorders and Stroke.
Introducing Stitches!
Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!
Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.